Filing Details
- Accession Number:
- 0001209191-13-012981
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-01 19:48:33
- Reporting Period:
- 2013-02-27
- Filing Date:
- 2013-03-01
- Accepted Time:
- 2013-03-01 19:48:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422996 | C. Juan Jaen | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Svp, Drug Discovery & Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-02-27 | 2,599 | $4.30 | 47,599 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-27 | 2,599 | $12.56 | 45,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-02-27 | 4,901 | $4.30 | 49,901 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-27 | 4,901 | $12.55 | 45,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-02-28 | 99 | $4.30 | 45,099 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-28 | 99 | $12.56 | 45,000 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-02-28 | 5,000 | $4.30 | 50,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-02-28 | 5,000 | $13.14 | 45,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-02-27 | 2,599 | $0.00 | 2,599 | $4.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-02-27 | 4,901 | $0.00 | 4,901 | $4.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-02-28 | 99 | $0.00 | 99 | $4.30 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2013-02-28 | 5,000 | $0.00 | 5,000 | $4.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 107,500 | 2017-02-06 | No | 4 | M | Direct | |
| 102,599 | 2017-02-06 | No | 4 | M | Direct | |
| 102,500 | 2017-02-06 | No | 4 | M | Direct | |
| 97,500 | 2017-02-06 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $12.36 to $12.85 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $12.36 to $12.85 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $12.56 to $13.40 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of February 27, 2013 and prior to this transaction, the option fully vested.
- Not applicable.
Billionaire Hedge Funds
